Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.71% | -21.33% | -133.39% | 39.29% | -1.72% |
| Total Depreciation and Amortization | -30.75% | -8.92% | -25.06% | -23.86% | -13.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.21% | 175.66% | 2,587.60% | -43.42% | -82.33% |
| Change in Net Operating Assets | -15.08% | 168.77% | -94.67% | -163.31% | -480.43% |
| Cash from Operations | 13.69% | 10.28% | 24.68% | 18.33% | -59.25% |
| Capital Expenditure | 95.44% | -54.52% | -80.82% | 56.94% | -306.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.86% | -- | -158.26% | -48.19% | 543.72% |
| Cash from Investing | -100.99% | -101.93% | -223.83% | -47.82% | 522.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 538.69% | 1,122.07% | 6,607.80% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 538.69% | 1,122.07% | 6,607.80% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -149.73% | -253.52% | 105.61% | 110.74% | 199.69% |